Free Trial

American Oncology Network (AONC) Competitors

American Oncology Network logo
$4.00 -0.29 (-6.76%)
(As of 01:26 PM ET)

AONC vs. AVHIW, AVHIU, ACONW, DHACW, CORBF, LFMDP, OTRKP, PIIIW, SHCRW, and TALKW

Should you be buying American Oncology Network stock or one of its competitors? The main competitors of American Oncology Network include Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), Aclarion (ACONW), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Sharecare (SHCRW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry.

American Oncology Network vs.

Achari Ventures Holdings Corp. I (NASDAQ:AVHIW) and American Oncology Network (NASDAQ:AONC) are both financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, profitability, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Achari Ventures Holdings Corp. IN/AN/AN/AN/AN/A
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, American Oncology Network had 1 more articles in the media than Achari Ventures Holdings Corp. I. MarketBeat recorded 1 mentions for American Oncology Network and 0 mentions for Achari Ventures Holdings Corp. I. Achari Ventures Holdings Corp. I's average media sentiment score of 0.00 equaled American Oncology Network'saverage media sentiment score.

Company Overall Sentiment
Achari Ventures Holdings Corp. I Neutral
American Oncology Network Neutral

Achari Ventures Holdings Corp. I and American Oncology Network both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Achari Ventures Holdings Corp. IN/AN/A
American Oncology NetworkN/AN/A

Company Net Margins Return on Equity Return on Assets
Achari Ventures Holdings Corp. IN/A N/A N/A
American Oncology Network N/A N/A N/A

Summary

American Oncology Network beats Achari Ventures Holdings Corp. I on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AONC vs. The Competition

MetricAmerican Oncology NetworkMedical Care Facilities IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.34B$5.10B$8.84B
Dividend YieldN/A3.92%5.04%4.07%
P/E RatioN/A244.2495.6214.26
Price / SalesN/A65.681,217.1987.73
Price / CashN/A13.6239.5936.27
Price / BookN/A2.336.946.36
Net IncomeN/A$52.40M$118.89M$225.56M
7 Day Performance14.29%0.55%-1.33%-0.10%
1 Month Performance26.98%-1.36%-3.17%2.02%
1 Year Performance-42.28%12.11%32.49%27.87%

American Oncology Network Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AONC
American Oncology Network
N/A$4.00
-6.8%
N/A-33.8%$0.00$1.34B0.001,520
AVHIW
Achari Ventures Holdings Corp. I
N/A$0.01
flat
N/AN/A$0.00N/A0.003
AVHIU
Achari Ventures Holdings Corp. I
N/A$10.00
flat
N/AN/A$0.00N/A0.003
ACONW
Aclarion
N/A$0.04
+43.9%
N/AN/A$0.00$49,289.000.007Gap Up
DHACW
Digital Health Acquisition
N/A$0.03
flat
N/A+77.3%$0.00N/A0.00N/A
CORBF
Global Cord Blood
N/A$1.25
flat
N/A+0.0%$0.00$196.12M0.001,202
LFMDP
LifeMD
N/A$22.00
flat
N/A+18.9%$0.00$193.06M0.00230
OTRKP
Ontrak
N/A$0.28
+0.0%
N/A-11.3%$0.00$10.84M0.00250
PIIIW
P3 Health Partners
N/A$0.02
flat
N/A-88.0%$0.00$1.48B0.00500
SHCRW
Sharecare
N/A$0.09
flat
N/AN/A$0.00$403.73M0.003,280
TALKW
Talkspace
N/A$0.13
-17.2%
N/A+60.3%$0.00$181.29M0.00500High Trading Volume

Related Companies and Tools


This page (NASDAQ:AONC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners